We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Lear Corporation's (LEA) Q2 Earnings Beat Estimates, Up Y/Y
Read MoreHide Full Article
Lear Corporation (LEA - Free Report) reported second-quarter 2018 adjusted earnings per share of $4.95, up 13% from the prior-year quarter figure. Also, the bottom line surpassed the Zacks Consensus Estimate of $4.91.
During the reported quarter, revenues increased 9% year over year to $5.58 billion. The top line slightly beat the Zacks Consensus Estimate of $5.56 billion. The year-over-year rise in sales was primarily due to the addition of new businesses in both the product segments, the acquisition of seating business of Grupo Antolin and the sales impact of obtaining control of certain affiliates, which were partially offset by a lower production volume on key Lear platforms.
Moreover, the company reported 7.2% increase in core operating earnings to $470.5 million in the reported quarter.
Lear Corporation Price, Consensus and EPS Surprise
Revenues at the Seating segment were $4.27 billion in the reported quarter compared with $4.03 billion recorded in second-quarter 2017. However, adjusted segment margin declined 10 basis points to 8.3%.
Revenues at the E-Systems segment totaled $1.31 billion in comparison with $1.1 billion recorded in the prior-year quarter. However, adjusted segment margin declined 90 basis points to 14%
Financials
Lear had $1.3 billion of cash and cash equivalents as of Jun 30, 2018, compared with $1.5 billion as of Dec 31, 2017. The company had long-term debt of $1.95 billion as of Jun 30, 2018, almost in line with the figure recorded on Dec 31, 2017.
At the end of second-quarter 2018, Lear’s free cash flow was $347.5 million in comparison with $413.2 million as of Jul 1, 2017.
Capital Deployment
During the reported quarter, Lear repurchased 718,000 shares for $140 million. As of the end of the second quarter, the company had a remaining share repurchase authorization of $1.2 billion.
2018 Outlook
The company has kept 2018 outlook unchanged. It anticipates sales in the year to be $21.8-$22 billion. Also, the company expects core operating earnings to be $1,790-$1,810 million.
Oshkosh has an expected long-term growth rate of 18.3%. Over the past year, shares of the company have moved up 7.3%.
AB Volvo has an expected long-term growth rate of 15%. Over the past year, shares of the company have gained 2.3%.
Fox Factory has an expected long-term growth rate of 15.8%. Shares of the company have risen 30.2% over the past year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Lear Corporation's (LEA) Q2 Earnings Beat Estimates, Up Y/Y
Lear Corporation (LEA - Free Report) reported second-quarter 2018 adjusted earnings per share of $4.95, up 13% from the prior-year quarter figure. Also, the bottom line surpassed the Zacks Consensus Estimate of $4.91.
During the reported quarter, revenues increased 9% year over year to $5.58 billion. The top line slightly beat the Zacks Consensus Estimate of $5.56 billion. The year-over-year rise in sales was primarily due to the addition of new businesses in both the product segments, the acquisition of seating business of Grupo Antolin and the sales impact of obtaining control of certain affiliates, which were partially offset by a lower production volume on key Lear platforms.
Moreover, the company reported 7.2% increase in core operating earnings to $470.5 million in the reported quarter.
Lear Corporation Price, Consensus and EPS Surprise
Lear Corporation Price, Consensus and EPS Surprise | Lear Corporation Quote
Segment Performances
Revenues at the Seating segment were $4.27 billion in the reported quarter compared with $4.03 billion recorded in second-quarter 2017. However, adjusted segment margin declined 10 basis points to 8.3%.
Revenues at the E-Systems segment totaled $1.31 billion in comparison with $1.1 billion recorded in the prior-year quarter. However, adjusted segment margin declined 90 basis points to 14%
Financials
Lear had $1.3 billion of cash and cash equivalents as of Jun 30, 2018, compared with $1.5 billion as of Dec 31, 2017. The company had long-term debt of $1.95 billion as of Jun 30, 2018, almost in line with the figure recorded on Dec 31, 2017.
At the end of second-quarter 2018, Lear’s free cash flow was $347.5 million in comparison with $413.2 million as of Jul 1, 2017.
Capital Deployment
During the reported quarter, Lear repurchased 718,000 shares for $140 million. As of the end of the second quarter, the company had a remaining share repurchase authorization of $1.2 billion.
2018 Outlook
The company has kept 2018 outlook unchanged. It anticipates sales in the year to be $21.8-$22 billion. Also, the company expects core operating earnings to be $1,790-$1,810 million.
Zacks Rank & Key Picks
Currently, Lear has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the auto space are Oshkosh Corporation (OSK - Free Report) , AB Volvo (VLVLY - Free Report) and Fox Factory Holding Corp. (FOXF - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Oshkosh has an expected long-term growth rate of 18.3%. Over the past year, shares of the company have moved up 7.3%.
AB Volvo has an expected long-term growth rate of 15%. Over the past year, shares of the company have gained 2.3%.
Fox Factory has an expected long-term growth rate of 15.8%. Shares of the company have risen 30.2% over the past year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>